Frederick J. Angulo

Pfizer, Inc.

235 East 42 Street

New York, NY 10017

United States

SCHOLARLY PAPERS

9

DOWNLOADS
Rank 12,819

SSRN RANKINGS

Top 12,819

in Total Papers Downloads

8,070

TOTAL CITATIONS
Rank 31,384

SSRN RANKINGS

Top 31,384

in Total Papers Citations

6

Scholarly Papers (9)

Actions:
Email selected abstracts
1.

Six-Month Effectiveness of BNT162B2 mRNA COVID-19 Vaccine in a Large US Integrated Health System: A Retrospective Cohort Study

Number of pages: 40 Posted: 23 Aug 2021
Sara Y. Tartof, Jeff M. Slezak, Heidi Fischer, Vennis Hong, Bradley K. Ackerson, Omesh N. Ranasinghe, Timothy B. Frankland, Oluwaseye A. Ogun, Joann M. Zamparo, Sharon Gray, Srinivas R. Valluri, Kaijie Pan, Frederick J. Angulo, Luis Jodar and John M. McLaughlin
Kaiser Permanente Southern California - Department of Research & Evaluation, Kaiser Permanente Southern California - Department of Research & Evaluation, Kaiser Permanente - Southern California Kaiser Permanente Medical Group, Kaiser Permanente Southern California - Department of Research & Evaluation, Kaiser Permanente Southern California, Kaiser Permanente - Southern California Kaiser Permanente Medical Group, Kaiser Permanente - Kaiser Permanente Center for Integrated Health Care Research, Kaiser Permanente Southern California - Department of Research & Evaluation, Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc. - Vaccines Medical Development & Scientific Affairs and Pfizer, Inc.
Downloads 5,614 (3,259)

Abstract:

Loading...

2.

Nationwide Vaccination Campaign with BNT162b2 in Israel Demonstrates High Vaccine Effectiveness and Marked Declines in Incidence of SARS-CoV-2 Infections and COVID-19 Cases, Hospitalizations, and Deaths

Number of pages: 24 Posted: 24 Mar 2021
Eric J. Haas, Frederick J. Angulo, John M. McLaughlin, Emilia Anis, Shepherd R. Singer, Farid Khan, Nati Brooks, Meir Smaja, Gabriel Mircus, Kaijie Pan, Jo Southern, David L. Swerdlow, Luis Jodar, Yeheskel Levy and Sharon Alroy-Preis
Ministry of Health (Israel) - Public Health Services, Pfizer, Inc., Pfizer, Inc., Ministry of Health (Israel) - Public Health Services, Ministry of Health (Israel) - Public Health Services, Pfizer, Inc., Ministry of Health (Israel) - Information Technology Department, Ministry of Health (Israel) - Information Technology Department, Pfizer Pharmaceuticals Israel Ltd, Pfizer, Inc., Pfizer, Inc. - Vaccines Medical Development & Scientific Affairs, Harvard University - Center for Communicable Disease Dynamics, Pfizer, Inc. - Vaccines Medical Development & Scientific Affairs, Ministry of Health (Israel) and Ministry of Health (Israel) - Department of Maternal and Child Health
Downloads 1,670 (23,403)
Citation 1

Abstract:

Loading...

COVID-19, SARS-CoV-2, vaccine effectiveness, prevention, mRNA vaccines, pandemic, observational study, epidemiology

3.

Infections, Hospitalizations, and Deaths Averted Via Direct Effects of the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine in a Nationwide Vaccination Campaign, Israel

Number of pages: 25 Posted: 13 May 2021
Eric J. Haas, John M. McLaughlin, Farid Khan, Frederick J. Angulo, Emilia Anis, Emilia Anis, Marc Lipsitch, Shepherd R. Singer, Gabriel Mircus, Nati Brooks, Meir Smaja, Kaijie Pan, Jo Southern, David L. Swerdlow, Luis Jodar, Yeheskel Levy and Sharon Alroy-Preis
Ministry of Health (Israel) - Public Health Services, Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Yale UniversityMinistry of Health (Israel) - Public Health Services, Harvard T.H. Chan School of Public Health - Center for Communicable Disease Dynamics, Ministry of Health (Israel) - Public Health Services, Pfizer Pharmaceuticals Israel Ltd, Ministry of Health (Israel) - Information Technology Department, Ministry of Health (Israel) - Information Technology Department, Pfizer, Inc., Pfizer, Inc. - Vaccines Medical Development & Scientific Affairs, Harvard University - Center for Communicable Disease Dynamics, Pfizer, Inc. - Vaccines Medical Development & Scientific Affairs, Ministry of Health (Israel) and Ministry of Health (Israel) - Department of Maternal and Child Health
Downloads 472 (131,691)
Citation 4

Abstract:

Loading...

COVID-19, SARS-CoV-2, cases averted, impact, hospitalizations, deaths, Israel, model, public health, pandemic

4.

Effectiveness of BNT162b2 mRNA COVID-19 Vaccine Against SARS-CoV-2 Variant Beta (B.1.351) Among Persons Identified Through Contact Tracing in Israel

Number of pages: 29 Posted: 13 Aug 2021
Shepherd R. Singer, Frederick J. Angulo, David L. Swerdlow, John M. McLaughlin, Itay Hazan, Netanel Ginish, Emilia Anis, Emilia Anis, Ella Mendelson, Orna Mor, Neta S. Zuckerman, Oran Erster, Jo Southern, Kaijie Pan, Gabriel Mircus, Marc Lipsitch, Eric J. Haas, Luis Jodar, Yeheskel Levy and Sharon Alroy-Preis
Ministry of Health (Israel) - Public Health Services, Pfizer, Inc., Harvard University - Center for Communicable Disease Dynamics, Pfizer, Inc., Ministry of Health (Israel), Israel Ministry of Health, Yale UniversityMinistry of Health (Israel) - Public Health Services, Sheba Medical Center - Central Virology Laboratory, Sheba Medical Center - Central Virology Laboratory, Sheba Medical Center - Central Virology Laboratory, Chaim Sheba Medical Center - Central Virology Laboratory, Pfizer, Inc. - Vaccines Medical Development & Scientific Affairs, Pfizer, Inc., Pfizer Pharmaceuticals Israel Ltd, Harvard T.H. Chan School of Public Health - Center for Communicable Disease Dynamics, Ministry of Health (Israel) - Public Health Services, Pfizer, Inc. - Vaccines Medical Development & Scientific Affairs, Ministry of Health (Israel) and Ministry of Health (Israel) - Department of Maternal and Child Health
Downloads 200 (327,227)
Citation 1

Abstract:

Loading...

5.

Incidence of Lyme Borreliosis in Germany: A Retrospective Observational Healthcare Claims Study

Number of pages: 24 Posted: 22 Nov 2023
Gordon Brestrich, Christine Hagemann, Joanna Diesing, Nils Kossack, James H. Stark, Andreas Pilz, Frederick J. Angulo, Holly Yu and Jochen Suess
Pfizer Pharma GmbH, Pfizer Pharma GmbH, Scientific Institute for Health Economics and Health System Research (WIG2 GmbH), Scientific Institute for Health Economics and Health System Research (WIG2 GmbH), Pfizer Biopharma Group, Pfizer Biopharma Group, Pfizer, Inc., Pfizer Biopharma Group and Brehm Memorial Center
Downloads 30 (1,036,422)

Abstract:

Loading...

Lyme borreliosis, Lyme neuroborreliosis, Lyme arthritis, epidemiology, incidence, Germany

6.

Borrelia Burgdorferi Sensu Lato Prevalence in Ixodes Scapularis from Canada: A Thirty-Year Summary and Meta-Analysis (1990-2020)

Number of pages: 32 Posted: 19 Mar 2024
Patrick Kelly, Ye Tan, Qi Yan, Madiha Shafquat, Alexander Davidson, Qiaoyi Xu, Maria Major, Kate Halsby, Ana Grajales, Julie Davis, Frederick J. Angulo, Jennifer C. Moïsi and James H. Stark
Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc. and Pfizer Biopharma Group
Downloads 27 (1,071,133)

Abstract:

Loading...

Lyme, Ixodes, scapularis, Borrelia, tick, surveillance, Canada, Epidemiology, Ontario, Quebec

7.

Increasing Prevalence of Borrelia Burgdorferi Sensu Lato in Ixodes Scapularis in Canada: A Meta-Analysis of Active and Passive Surveillance Studies (2000-2023)

Number of pages: 26 Posted: 26 Jan 2024
Patrick Kelly, Ye Tan, Qi Yan, Madiha Shafquat, Qiaoyi Xu, Maria Major, Kate Halsby, Ana Grajales, Julie Davis, Frederick J. Angulo, Jennifer C. Moïsi and James H. Stark
Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc. and Pfizer Biopharma Group
Downloads 20 (1,156,817)

Abstract:

Loading...

Lyme, Ixodes, Borrelia, tick, surveillance, Canada

8.

Prevalence of Borrelia Burgdorferi Sensu Lato Infection in the Czech Republic

Number of pages: 34 Posted: 04 Dec 2024
Frederick J. Angulo, Roman Chlibek, Jan Smetana, Kateřina Kybicová, Martina Malikova, Alexandra Loew-Baselli, Ye Tan, Aleš Ondřejíček, Gordon Brestrich, Andreas Pilz, Jennifer C. Moïsi and James H. Stark
Pfizer, Inc., affiliation not provided to SSRN, affiliation not provided to SSRN, National Institute of Public Health, affiliation not provided to SSRN, affiliation not provided to SSRN, Pfizer, Inc., affiliation not provided to SSRN, Pfizer Pharma GmbH, Pfizer Biopharma Group, Pfizer, Inc. and Pfizer Biopharma Group
Downloads 19 (1,169,087)

Abstract:

Loading...

Lyme borreliosis, Lyme disease, epidemiology, disease burden, surveillance, tick-borne disease.

9.

Using Meta-Analysis to Estimate the Incidence of Lyme Borreliosis Clinical Manifestations in Denmark, Ireland and Sweden Based on Publicly-Available Lyme Neuroborreliosis Data

Number of pages: 22 Posted: 14 Apr 2025
Gordon Brestrich, Madiha Shafquat, Frederick J. Angulo, Alexander Davidson, Ye Tan, Kate Halsby, Julie Davis, Jennifer C. Moïsi and James H. Stark
Pfizer Pharma GmbH, Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., affiliation not provided to SSRN, Pfizer, Inc., Pfizer, Inc. and Pfizer Biopharma Group
Downloads 18 (1,181,310)

Abstract:

Loading...

Lyme borreliosis, Lyme neuroborreliosis, Lyme arthritis, Epidemiology, Incidence, Sweden, Denmark, Ireland